
Sign up to save your podcasts
Or


Dr Zylke provides summary and commentary on the March 28, 2012 issue of JAMA, the Journal of the American Medical Association. Imatinib for Gastrointestinal Stromal Tumor, Cardiovascular Health Metrics and Mortality, Asthma Medication Costs and Health Care Use, Myotonic Dystrophy and Conduction System Disease, Lipids, Cardiovascular Events, and Statin Therapy, Are medical conferences useful?, Innovative health care models and financing.
By JAMA Network3.9
127127 ratings
Dr Zylke provides summary and commentary on the March 28, 2012 issue of JAMA, the Journal of the American Medical Association. Imatinib for Gastrointestinal Stromal Tumor, Cardiovascular Health Metrics and Mortality, Asthma Medication Costs and Health Care Use, Myotonic Dystrophy and Conduction System Disease, Lipids, Cardiovascular Events, and Statin Therapy, Are medical conferences useful?, Innovative health care models and financing.

327 Listeners

546 Listeners

705 Listeners

500 Listeners

302 Listeners

260 Listeners

908 Listeners

3,382 Listeners

1,148 Listeners

90 Listeners

515 Listeners

363 Listeners

265 Listeners

438 Listeners

271 Listeners